Medical News

RSS

Enzon Pharmaceuticals’ outstanding principal balance of 4% convertible notes is now $134.5M

Enzon Pharmaceuticals, Inc. today announced the results from the recent tender and increased conversion periods of the 4 percent convertible notes due in 2013. As a result of the sale of the specialty pharmaceutical business on January 29, 2010, the Company was required to offer to repurchase for cash any and all of its convertible notes at face value. This offer expired on March 5, 2010 and no notes were tendered.

8 Mar 2010

Butler Health System to implement Alpha Systems' enterprise EDM solution

Alpha Systems, a premier provider of electronic data and document management solutions, today announced that Butler Health System (Butler), an innovative healthcare provider located in Pennsylvania, has named Alpha Systems their vendor of choice for enterprise electronic document management (EDM) software. This move is designed to improve Butler’s communication across the enterprise while moving the healthcare provider closer to a paperless environment.

8 Mar 2010

NOVAVAX' Stage B 2009 H1N1 VLP pandemic influenza vaccine study in Mexico: Enrollment complete

Novavax, Inc. announced today that the enrollment of over 3,500 subjects in Mexico has been completed in Stage B of its pivotal 2009 H1N1 virus-like-particle (VLP) pandemic influenza vaccine study. With the 1,000 subjects already enrolled in Stage A of the trial, the enrollment in this pivotal trial is now complete with over 4,500 subjects.

8 Mar 2010

Genta announces private placement of Convertible Notes for $25M

Genta Incorporated announced today that the Company has entered into definitive agreements with institutional investors for a private placement of Convertible Notes totaling $25 million in gross proceeds. The transaction is expected to close on or about March 10, 2010, subject to the satisfaction of customary closing conditions.

8 Mar 2010

Ascension Orthopedics launches PyroTITAN Humeral Resurfacing Arthroplasty System

Ascension Orthopedics, Inc., a leader in orthopedic extremity implants, announces the international market launch of the PyroTITAN™ Humeral Resurfacing Arthroplasty System at the American Academy of Orthopaedic Surgeons Annual Conference in New Orleans, LA, March 9-13, 2010. Designed to meet the unique soft tissue biocompatibility requirements of the shoulder joint, the PyroTITAN humeral resurfacing implant is the first commercially-available, human shoulder arthroplasty prosthesis made of PyroCarbon.

8 Mar 2010

Positive data from Argos Therapeutics' AGS-003 Phase 2 trial for mRCC

Argos Therapeutics today announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly diagnosed patients with metastatic renal cell carcinoma (mRCC). The data were discussed March 7 in a poster presentation at the ASCO Genitourinary Cancers Symposium.

8 Mar 2010

Ricerca Biosciences to acquire Discovery and Preclinical business of MDS Pharma Services

Ricerca Biosciences, LLC, announced today the finalization of the acquisition of the Discovery and Preclinical business of MDS Pharma Services with facilities and almost 600 associates in Bothell, Washington; Lyon, France; and Taipei, Taiwan.

8 Mar 2010

Luminetx, Alliance Medical sign exclusive national sales distribution agreement

Luminetx®, a division of Christie Medical Holdings, Inc. and recently acquired by Christie Digital Systems USA, Inc., has signed an exclusive national sales distribution agreement with New Alliance of Independent Medical Distributors, Inc., DBA Alliance Medical. The agreement, effective last month, aligns the medical device company with Alliance Medical, the nation’s largest consortium of specialty medical sales distribution companies for intravenous devices, with comprehensive access to the U.S. acute, oncology and home health markets.

8 Mar 2010

Residential recovery program to aid women struggling with substance abuse

On Tuesday, March 9, 2010 at 3:30 pm, The W. Garfield Weston Foundation will present The Salvation Army Homestead (78 Admiral Rd, Toronto) a residential recovery program for women struggling with substance abuse, with a donation of $1.5 million for urgently needed building renovations.

8 Mar 2010

DATATRAK CRO Connect Program: Kreara Solutions joins global list

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that Kreara Solutions Pvt Ltd. has become the latest Contract Research Organization (CRO) to join the global list of DATATRAK CRO Connect partners.

8 Mar 2010

VIVUS granted three additional patents for Qnexa

VIVUS, Inc. today announced the issuance of three additional patents by the U.S. Patent and Trademark Office (USPTO) covering Qnexa, an investigational new drug candidate for the treatment of obesity. The three new patents are the second, third, and fourth patents to be granted in a series of patent applications VIVUS has filed that are directed to the Qnexa product and methods of using Qnexa in various therapeutic applications.

8 Mar 2010

ThermalTherapeutic Systems receives FDA clearance for VERATHERM Portable Hyperthermic Perfusion System

ThermalTherapeutic Systems, Inc. today announced that the FDA has cleared the company to market its VERATHERM™ Portable Hyperthermic Perfusion System effective immediately.

8 Mar 2010

GeneGo's industry-FDA MetaTox partnership program: Tools and contents released

GeneGo announces the release of the first set of tools and content to come out of its industry-FDA MetaTox™ partnership program. The MetaTox partnership is developing a unique comprehensive systems toxicology suite designed for compound safety assessment in chemical and pharmaceutical R&D.

8 Mar 2010

New nutrition product to address effects of Glycation

After an extensive on going research program, Mineral BioSciences LLC a division of Global Organics Group is proud to announce the introduction of TOTALA® Nutrients, an ingredient that promises to have a profound effect on the nutrition industry.

8 Mar 2010

Acceptance of initial regulatory filings for BMS-PCSK9Rx triggers $6M milestone payment to Isis Pharmaceuticals

Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.

8 Mar 2010

NICE rejects azacitidine for treatment of MDS in patients ineligible for stem cell transplants

A drug for treating a group of conditions that affect the bone marrow is unlikely to be made available on the NHS in England and Wales after the body which provides independent advice on treatments said that it is unlikely to be cost-effective.

8 Mar 2010

Centric Health's 2009 revenues up 132%

Centric Health Corporation, a diversified healthcare company, today announced its financial results for the fourth quarter and year ended December 31, 2009.

8 Mar 2010

Global Genes Project: World Rare Disease Day 2010, a tremendous success

The Global Genes Project, a worldwide rare disease awareness initiative, today announced the success from its World Rare Disease Day 2010 efforts and laid out plans for future rare disease awareness campaigns.

8 Mar 2010

Key Life Benefits, Boomer Authority partner to offer affordable health and lifestyle benefits

Boomer Authority™ and Key Life Benefits, a national resource for supplemental benefits, have partnered to offer businesses, individuals, social networking communities, and organizations health and lifestyle products and services at substantial cost saving prices.

8 Mar 2010

National Week of Prayer for the Healing of AIDS in the U.S. and the World

The National Week of Prayer for the Healing of AIDS begins Sunday, March 7th – Saturday, March 13th, 2010, with Churches, Synagogues, Temples and Homes calling Americans to teach, advocate and pray for the healing of AIDS in the United States and the World.

8 Mar 2010

Medical News

Enzon Pharmaceuticals’ outstanding principal balance of 4% convertible notes is now $134.5M

Butler Health System to implement Alpha Systems' enterprise EDM solution

NOVAVAX' Stage B 2009 H1N1 VLP pandemic influenza vaccine study in Mexico: Enrollment complete

Genta announces private placement of Convertible Notes for $25M

Ascension Orthopedics launches PyroTITAN Humeral Resurfacing Arthroplasty System

Positive data from Argos Therapeutics' AGS-003 Phase 2 trial for mRCC

Ricerca Biosciences to acquire Discovery and Preclinical business of MDS Pharma Services

Luminetx, Alliance Medical sign exclusive national sales distribution agreement

Residential recovery program to aid women struggling with substance abuse

DATATRAK CRO Connect Program: Kreara Solutions joins global list

VIVUS granted three additional patents for Qnexa

ThermalTherapeutic Systems receives FDA clearance for VERATHERM Portable Hyperthermic Perfusion System

GeneGo's industry-FDA MetaTox partnership program: Tools and contents released

New nutrition product to address effects of Glycation

Acceptance of initial regulatory filings for BMS-PCSK9Rx triggers $6M milestone payment to Isis Pharmaceuticals

NICE rejects azacitidine for treatment of MDS in patients ineligible for stem cell transplants

Centric Health's 2009 revenues up 132%

Global Genes Project: World Rare Disease Day 2010, a tremendous success

Key Life Benefits, Boomer Authority partner to offer affordable health and lifestyle benefits

National Week of Prayer for the Healing of AIDS in the U.S. and the World

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News